These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31160496)

  • 21. Association between Gout, Urate-Lowering Therapy, and Risk of Developing Type 2 Diabetes Mellitus: A Nationwide Population-Based Retrospective Cohort Study.
    Fang YJ; Chung YL; Lin CL; Lim YP
    Biomed Res Int; 2020; 2020():6358954. PubMed ID: 32775432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus.
    Chang HW; Lin YW; Lin MH; Lan YC; Wang RY
    PLoS One; 2019; 14(1):e0210085. PubMed ID: 30615649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dyslipidemia, Alcohol Consumption, and Obesity as Main Factors Associated With Poor Control of Urate Levels in Patients Receiving Urate-Lowering Therapy.
    Latourte A; Bardin T; Clerson P; Ea HK; Flipo RM; Richette P
    Arthritis Care Res (Hoboken); 2018 Jun; 70(6):918-924. PubMed ID: 28834411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is allopurinol use associated with an excess risk of osteoporotic fracture? A National Prescription Registry study.
    Dennison EM; Rubin KH; Schwarz P; Harvey NC; Bone KW; Cooper C; Abrahamsen B
    Arch Osteoporos; 2015; 10():36. PubMed ID: 26481934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy.
    Gupta MK; Singh JA
    Drugs; 2019 Apr; 79(5):531-541. PubMed ID: 30868398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence and persistence to urate-lowering therapies in the Irish setting.
    McGowan B; Bennett K; Silke C; Whelan B
    Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence with urate-lowering therapies for the treatment of gout.
    Harrold LR; Andrade SE; Briesacher BA; Raebel MA; Fouayzi H; Yood RA; Ockene IS
    Arthritis Res Ther; 2009; 11(2):R46. PubMed ID: 19327147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lesinurad/allopurinol (Duzallo) for gout-associated hyperuricemia.
    Med Lett Drugs Ther; 2017 Nov; 59(1533):182-183. PubMed ID: 29125593
    [No Abstract]   [Full Text] [Related]  

  • 29. Gout incidence and management during the COVID-19 pandemic in England, UK: a nationwide observational study using OpenSAFELY.
    Russell MD; Massey J; Roddy E; MacKenna B; Bacon S; Goldacre B; Andrews CD; Hickman G; Mehrkar A; Mahto A; Rutherford AI; Patel S; Adas MA; Alveyn E; Nagra D; Bechman K; Ledingham JM; Hudson J; Norton S; Cope AP; Galloway JB
    Lancet Rheumatol; 2023 Oct; 5(10):e622-e632. PubMed ID: 38251486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasound Evaluation of Three Outcome Domains in the Follow-up of Urate-Lowering Therapy in Gout: An Observational Study.
    Zhang W; Zhao D; Wu M; Chen W; Jin Z; Zhang H
    Ultrasound Med Biol; 2021 Jun; 47(6):1495-1505. PubMed ID: 33785225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eligibility for and prescription of urate-lowering treatment in patients with incident gout in England.
    Kuo CF; Grainge MJ; Mallen C; Zhang W; Doherty M
    JAMA; 2014 Dec 24-31; 312(24):2684-6. PubMed ID: 25536262
    [No Abstract]   [Full Text] [Related]  

  • 32. Crystal arthropathies: recognizing and treating "the gouch".
    Quillen DM
    Prim Care; 2010 Dec; 37(4):703-11, v. PubMed ID: 21050952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lowering Serum Urate With Urate-Lowering Therapy to Target and Incident Fracture Among People With Gout.
    Wei J; Choi HK; Dalbeth N; Lane NE; Wu J; Lyu H; Zeng C; Lei G; Zhang Y
    Arthritis Rheumatol; 2023 Aug; 75(8):1456-1465. PubMed ID: 36940260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation and treatment of gout as a chronic disease.
    Perez-Ruiz F; Herrero-Beites AM
    Adv Ther; 2012 Nov; 29(11):935-46. PubMed ID: 23104464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink.
    Roddy E; Bajpai R; Forrester H; Partington RJ; Mallen CD; Clarson LE; Padmanabhan N; Whittle R; Muller S
    Ann Rheum Dis; 2023 Dec; 82(12):1618-1625. PubMed ID: 37788904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The management of gout at an academic healthcare center in Beijing: a physician survey.
    Fang W; Zeng X; Li M; Chen LX; Schumacher HR; Zhang F
    J Rheumatol; 2006 Oct; 33(10):2041-9. PubMed ID: 17014019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial.
    Doherty M; Jenkins W; Richardson H; Sarmanova A; Abhishek A; Ashton D; Barclay C; Doherty S; Duley L; Hatton R; Rees F; Stevenson M; Zhang W
    Lancet; 2018 Oct; 392(10156):1403-1412. PubMed ID: 30343856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and tolerability of available urate-lowering drugs: a critical review.
    Strilchuk L; Fogacci F; Cicero AF
    Expert Opin Drug Saf; 2019 Apr; 18(4):261-271. PubMed ID: 30915866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors.
    Dehlin M; Jacobsson L; Roddy E
    Nat Rev Rheumatol; 2020 Jul; 16(7):380-390. PubMed ID: 32541923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis.
    Perez-Ruiz F; Herrero-Beites AM; Carmona L
    Arthritis Rheum; 2011 Dec; 63(12):4002-6. PubMed ID: 21898351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.